Compare Gigacloud Technology Inc (GCT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs TransMedics Group Inc — how do they compare? Gigacloud Technology Inc trades at $57.26 (market cap $2.02B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and TransMedics Group Inc for 24 Days on average.
| GCT | TMDX | |
|---|---|---|
Market Cap | $2.02B | $2.74B |
Volume | 1,020,985 | 949,331 |
Sector | Technology | Health |
52-Week High | $57.26 | $150.42 |
52-Week Low | $25.46 | $61.99 |
Typical Hold Time | 21 Days | 24 Days |
Enterprise Value | $2.14B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $56.42, up 0.82% with strong technical momentum as moving averages signal bullish alignment. The company demonstrates robust fundamentals with consistent earnings beats, 10.65% net margins, and 32.34% ROE. Revenue growth from $1.29B to $1.5B projected for 2026 supports valuation at 13.44 P/E. Recent news highlights institutional interest and European expansion driving optimism.
Outlook remains positive given earnings momentum and reasonable valuation, though risks include insider selling and competitive pressures. Analyst consensus favors Buy with $32.50 target, but current price exceeds consensus suggesting cautious near-term positioning may be warranted despite strong operational performance.
TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.
The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
